Online citations, reference lists, and bibliographies.
← Back to Search

Curcumin-Loaded Polymeric Nanoparticle: A Promising Route For The Treatment Of Cancer

Chinmayee Saikia, M. Sarmah, M. Das, Anand M. Ramteke, T. Maji
Published 2015 · Chemistry

Save to my Library
Download PDF
Analyze on Scholarcy
Share
This paper references
Anti-tumour studies of metal chelates of synthetic curcuminoids.
V. D. John (2002)
10.1016/j.bcp.2009.09.003
Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo.
P. Anand (2010)
10.1088/0957-4484/22/3/035101
Surface functionalization of PLGA nanoparticles by non-covalent insertion of a homo-bifunctional spacer for active targeting in cancer therapy.
S. Thamake (2011)
10.1211/jpp.59.1.0010
Uptake characteristics of liposomes by rat alveolar macrophages: influence of particle size and surface mannose modification
S. Chono (2007)
10.1007/BF01076459
Influence of dietary curcumin and cholesterol on the progression of experimentally induced diabetes in albino rat
P. Suresh Babu (2005)
10.1016/j.biomaterials.2010.06.051
Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods.
Y. Qiu (2010)
10.3109/10717544.2012.721143
Native and β-cyclodextrin-enclosed curcumin: entrapment within liposomes and their in vitro cytotoxicity in lung and colon cancer
S. Rahman (2012)
10.3109/02652049709006812
Optimization of the preparation of loperamide-loaded poly (L-lactide) nanoparticles by high pressure emulsification-solvent evaporation.
M. Ueda (1997)
10.1016/0378-5173(90)90201-E
Oxygen radical scavenging activity of curcumin
Elizabeth Kunchandy (1990)
10.1016/j.jcis.2011.12.063
Elaboration of chitosan-coated nanoparticles loaded with curcumin for mucoadhesive applications.
L. Mazzarino (2012)
10.7314/APJCP.2013.14.1.409
In vivo evaluation of curcumin-loaded nanoparticles in a A549 xenograft mice model.
H. Yin (2013)
10.3109/02652048709031579
p-Nitrophenetole deethylase activity of rat liver microsomes entrapped in polyelectrolyte capsules.
C. Jung (1987)
10.1002/JPS.21037
Solubilization of hydrophobic drugs by methoxy poly(ethylene glycol)-block-polycaprolactone diblock copolymer micelles: theoretical and experimental data and correlations.
K. Letchford (2008)
10.1016/S1389-1723(02)80202-X
Functional magnetic particles for medical application.
M. Shinkai (2002)
10.1111/j.2042-7158.1973.tb09131.x
Pharmacology of diferuloyl methane (curcumin), a non‐steroidal anti‐inflammatory agent *
R. C. Srimal (1973)
10.1016/j.jcis.2011.04.006
Curcumin-loaded biocompatible thermoresponsive polymeric nanoparticles for cancer drug delivery.
N. S. Rejinold (2011)
10.1023/A:1022853007710
Modulatory effect of Henna leaf (Lawsonia inermis) on drug metabolising phase I and phase II enzymes, antioxidant enzymes, lipid peroxidation and chemically induced skin and forestomach papillomagenesis in mice
Trisha Dasgupta (2004)
10.1007/BF01513189
The aggregation behavior of poly-(oxyethylene)-poly-(oxypropylene)-poly-(oxyethylene)-block-copolymers in aqueous solution
G. Wanka (1990)
Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining.
C. Gillett (1994)
10.1016/j.addr.2012.10.007
Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery.
Yeonhee Yun (2013)
10.1023/A:1015942306801
Protein Precoating of Polylactide Microspheres Containing a Lipophilic Immunopotentiator for Enhancement of Macrophage Phagocytosis and Activation
Y. Tabata (2004)
10.1211/002235703765344496
Efficacy and irritancy of enhancers on the in‐vitro and in‐vivo percutaneous absorption of curcumin
Jia-You Fang (2003)
10.1155/2014/186864
A Review on Antibacterial, Antiviral, and Antifungal Activity of Curcumin
Soheil Zorofchian Moghadamtousi (2014)
10.1016/j.ijbiomac.2011.04.008
Biocompatible, biodegradable and thermo-sensitive chitosan-g-poly (N-isopropylacrylamide) nanocarrier for curcumin drug delivery.
N. S. Rejinold (2011)
10.1080/03639040601050163
Development and In Vitro Evaluation of Surface Modified Poly(lactide-co-glycolide) Nanoparticles with Chitosan-4-Thiobutylamidine
V. Grabovac (2007)
10.1002/BMC.795
High-performance liquid chromatography analysis of curcumin in rat plasma: application to pharmacokinetics of polymeric micellar formulation of curcumin.
Zengshuan Ma (2007)
10.1006/JCIS.1997.4880
Study of the Gelation Process of Polyethylene Oxidea -Polypropylene Oxideb -Polyethylene Oxidea Copolymer (Poloxamer 407) Aqueous Solutions
Cabana (1997)
10.2147/IJN.S29290
Curcumin-loaded magnetic nanoparticles for breast cancer therapeutics and imaging applications
Murali M Yallapu (2012)
10.1038/bjc.1995.13
Oesophageal cancer and amplification of the human cyclin D gene CCND1/PRAD1.
J. Adélaide (1995)
10.1016/J.JINORGBIO.2004.09.011
Complementary inhibition of synoviocyte, smooth muscle cell or mouse lymphoma cell proliferation by a vanadyl curcumin complex compared to curcumin alone.
K. Thompson (2004)
10.3892/IJO.30.4.905
Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer.
S. Shankar (2007)
10.1002/mnfr.201100307
Anti-proliferative effect of curcumin on melanoma cells is mediated by PDE1A inhibition that regulates the epigenetic integrator UHRF1.
A. Abusnina (2011)
10.1016/J.CGH.2006.03.020
Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis.
M. Cruz-Correa (2006)
10.1158/0008-5472.CAN-07-6734
Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1.
H. Chen (2008)
10.1016/J.FREERADBIOMED.2003.09.011
Manganese complexes of curcumin and its derivatives: evaluation for the radical scavenging ability and neuroprotective activity.
O. Vajragupta (2003)
10.1039/C2RA20702H
Preparation and evaluation of the effect of particle size on the properties of chitosan-montmorillonite nanoparticles loaded with isoniazid
Nibedita Banik (2012)
10.1158/0008-5472.CAN-09-4362
Injectable sustained release microparticles of curcumin: a new concept for cancer chemoprevention.
Komal Shahani (2010)
10.1038/aps.2012.34
Enhancement of cellular uptake and cytotoxicity of curcumin-loaded PLGA nanoparticles by conjugation with anti-P-glycoprotein in drug resistance cancer cells
Wanisa Punfa (2012)
10.1111/j.1524-4741.2009.00709.x
Curcumin Suppresses the Paclitaxel‐Induced Nuclear Factor‐κB in Breast Cancer Cells and Potentiates the Growth Inhibitory Effect of Paclitaxel in a Breast Cancer Nude Mice Model
H. J. Kang (2009)
10.1139/W10-117
Curcumin as a promising anticandidal of clinical interest.
K. Neelofar (2011)
10.1523/JNEUROSCI.21-21-08370.2001
The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse
G. Lim (2001)
10.1111/J.1600-0773.1978.TB02240.X
A study on the fate of curcumin in the rat.
B. Wahlström (1978)
10.1038/nnano.2008.30
Nanoparticle-mediated cellular response is size-dependent.
W. Jiang (2008)
10.1002/mnfr.201000310
Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin.
V. Kakkar (2011)
10.1158/1535-7163.MCT-06-0556
Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer
L. Li (2007)
10.1002/CBER.187000301196
Ueber Curcumin, den Farbstoff der Curcumawurzel
F. Daube (1870)
10.1166/JBN.2009.1038
Curcumin loaded pH-sensitive nanoparticles for the treatment of colon cancer.
D. Prajakta (2009)
10.1158/1078-0432.CCR-04-0744
Phase I Clinical Trial of Oral Curcumin
R. Sharma (2004)
10.1002/STAR.201300277
Crosslinked thiolated starch coated Fe3O4 magnetic nanoparticles: Effect of montmorillonite and crosslinking density on drug delivery properties
Chinmayee Saikia (2014)
10.1093/abbs/gmr011
Curcumin delivery by methoxy polyethylene glycol-poly(caprolactone) nanoparticles inhibits the growth of C6 glioma cells.
Junfei Shao (2011)
Preliminary study on antirheumatic activity of curcumin (diferuloyl methane).
S. D. Deodhar (1980)
10.1016/0021-9797(92)90079-2
Optimization of polyalkylcyanoacrylate nanoparticle preparation: Influence of sulfur dioxide and pH on nanoparticle characteristics
F. Lescure (1992)
10.1055/S-2006-960004
Pharmacology of Curcuma longa.
H. P. Ammon (1991)
10.1016/0142-9612(96)85754-1
Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers.
K. Athanasiou (1996)
10.1016/J.JCHROMB.2007.03.010
Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS.
Kuo-Yi Yang (2007)
10.1016/0304-3835(96)04357-1
Curcumin inhibits the proliferation and cell cycle progression of human umbilical vein endothelial cell.
A. Singh (1996)
10.1038/484044a
Cancer: Limitations of therapies exposed
O. Casanovas (2012)
10.1016/j.ejps.2009.02.019
Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer.
J. Shaikh (2009)
10.1016/j.jcis.2010.05.022
Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells.
Murali M Yallapu (2010)
10.1016/j.carbpol.2013.02.029
In vitro and in vivo evaluation of curcumin loaded lauroyl sulphated chitosan for enhancing oral bioavailability.
R. Shelma (2013)
10.1021/mp800240j
Coadministration of Paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells.
Srinivas Ganta (2009)
10.1080/01635580802416703
Prevention and Treatment of Pancreatic Cancer by Curcumin in Combination With Omega-3 Fatty Acids
M. Swamy (2008)
10.3892/IJO.21.2.379
Curcumin inhibits cell cycle progression of immortalized human umbilical vein endothelial (ECV304) cells by up-regulating cyclin-dependent kinase inhibitor, p21WAF1/CIP1, p27KIP1 and p53.
Myung-Jin Park (2002)
Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy.
A. Mukerjee (2009)
10.1016/j.nano.2011.07.011
Curcumin-loaded γ-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma.
S. Dhule (2012)
10.1016/J.JCONREL.2004.10.012
Influence of molecular weight on oral absorption of water soluble chitosans.
S. Chae (2005)
10.1007/978-0-387-46401-5_2
Highly active anticancer curcumin analogues.
Cara A Mosley (2007)
10.1021/nn100262h
Rapid uptake of gold nanorods by primary human blood phagocytes and immunomodulatory effects of surface chemistry.
M. Bartneck (2010)
10.1016/0006-2952(89)90151-2
Oxidation of polyethylene glycols by alcohol dehydrogenase.
D. Herold (1989)
10.1021/bm800683f
Fluorescence study of the curcumin-casein micelle complexation and its application as a drug nanocarrier to cancer cells.
A. Sahu (2008)
10.1055/S-2006-957450
Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers.
G. Shoba (1998)
10.4291/wjgp.v2.i1.1
Therapeutic potential of curcumin in gastrointestinal diseases.
S. A. Rajasekaran (2011)
10.1248/BPB.28.1438
Elucidation of anti-allergic activities of curcumin-related compounds with a special reference to their anti-oxidative activities.
M. Suzuki (2005)
10.1021/CR030441B
Chitosan chemistry and pharmaceutical perspectives.
M. Kumar (2004)
10.1016/j.carbpol.2013.01.014
Galactosylated chitosan-polycaprolactone nanoparticles for hepatocyte-targeted delivery of curcumin.
N. Zhou (2013)
10.1016/J.COLSURFA.2010.09.011
Nanosized magnetofluorescent Fe3O4-curcumin conjugate for multimodal monitoring and drug targeting
L. Tran (2010)
10.1208/s12249-009-9264-8
Effect of Cyclodextrin Complexation of Curcumin on its Solubility and Antiangiogenic and Anti-inflammatory Activity in Rat Colitis Model
Vivek R. Yadav (2009)
10.1053/GAST.1996.V110.PM8608874
Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis.
N. Arber (1996)
10.1016/j.actbio.2008.04.021
Synthesis of novel biodegradable and self-assembling methoxy poly(ethylene glycol)-palmitate nanocarrier for curcumin delivery to cancer cells.
A. Sahu (2008)
10.1038/sj.bjp.0701914
Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells
H. W. Chen (1998)
10.1093/jn/130.2.467S
Progress in cancer chemoprevention: development of diet-derived chemopreventive agents.
G. Kelloff (2000)
10.1142/S0192415X10007890
Therapeutic efficacy evaluation of curcumin on human oral squamous cell carcinoma xenograft using multimodalities of molecular imaging.
Yu-Chuan Lin (2010)
10.3109/02652048.2011.590615
Formulation of curcumin-loaded solid lipid nanoparticles produced by fatty acids coacervation technique
D. Chirio (2011)
10.1093/AJCN/64.5.761
Curcumin protects against 4-hydroxy-2-trans-nonenal-induced cataract formation in rat lenses.
S. Awasthi (1996)
10.1016/J.CARBPOL.2008.11.002
Chitins and chitosans for the repair of wounded skin, nerve, cartilage and bone
R. Muzzarelli (2009)
10.1021/MP700113R
Bioavailability of curcumin: problems and promises.
P. Anand (2007)
10.1016/j.ejpb.2008.09.028
Mucoadhesive polymeric platforms for controlled drug delivery.
G. Andrews (2009)
10.1093/JAC/DKL128
Oral nanoparticle-based antituberculosis drug delivery to the brain in an experimental model.
R. Pandey (2006)
10.1016/S0168-3659(02)00271-7
Pluronic F127 gel formulations of deslorelin and GnRH reduce drug degradation and sustain drug release and effect in cattle.
J. Wenzel (2002)
10.1016/S0006-2952(00)00489-5
Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of IkappaB kinase and NFkappaB activation in macrophages.
M. Pan (2000)
10.1016/J.JPBA.2005.09.032
Validated LC/MS/MS assay for curcumin and tetrahydrocurcumin in rat plasma and application to pharmacokinetic study of phospholipid complex of curcumin.
A. Liu (2006)
10.1016/J.BIOMATERIALS.2005.04.041
Influence of polysaccharide coating on the interactions of nanoparticles with biological systems.
C. Lemarchand (2006)
Biotransformation of curcumin through reduction and glucuronidation in mice.
M. Pan (1999)
10.1023/A:1006829010327
Influence of retinol deficiency and curcumin/turmeric feeding on tissue microsomal membrane lipid peroxidation and fatty acids in rats
S. Kaul (2004)
10.1016/J.JMMM.2005.01.064
Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system
T. Neuberger (2005)
10.1158/1078-0432.CCR-08-1511
Curcumin Inhibits Prosurvival Pathways in Chronic Lymphocytic Leukemia B Cells and May Overcome Their Stromal Protection in Combination with EGCG
A. Ghosh (2009)
10.1016/J.COLSURFB.2006.09.012
Development and characterization of new insulin containing polysaccharide nanoparticles.
B. Sarmento (2006)
Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer.
J. Bártková (1995)
Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences.
G. Garcea (2005)
10.1016/j.nano.2009.05.009
Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells.
R. Das (2010)
10.2147/IJN.S33607
Preparation and in vivo pharmacokinetics of curcumin-loaded PCL-PEG-PCL triblock copolymeric nanoparticles
Runliang Feng (2012)
10.1016/S0939-6411(99)00039-9
Polymeric micelles - a new generation of colloidal drug carriers.
M. Jones (1999)
10.1016/J.BIOMATERIALS.2006.03.039
Parameters influencing the stealthiness of colloidal drug delivery systems.
A. Vonarbourg (2006)
10.1562/0031-8655(2003)077<0597:PSOBOC>2.0.CO;2
Photophysical Studies on Binding of Curcumin to Bovine Serum Albumin¶
A. Barik (2003)
10.1016/J.FOODCHEM.2008.12.036
Antioxidant, antimutagenic and antibacterial activities of curcumin-β-diglucoside
K. S. Parvathy (2009)
10.4103/0974-8490.62954
Colon targeted curcumin delivery using guar gum
A. Singhal (2010)
10.1016/J.COLSURFA.2011.08.031
Polymeric micelles for parenteral delivery of curcumin: Preparation, characterization and in vitro evaluation
L. Song (2011)
10.1016/J.CARBPOL.2010.08.008
Efficient water soluble O-carboxymethyl chitosan nanocarrier for the delivery of curcumin to cancer cells
A. Anitha (2011)
10.1021/jf103873k
Modification of curcumin with polyethylene glycol enhances the delivery of curcumin in preadipocytes and its antiadipogenic property.
C. Y. Kim (2011)
10.1002/jps.22785
Liposomal delivery system enhances anti-inflammatory properties of curcumin.
Purusotam Basnet (2012)
10.1074/JBC.275.14.10405
Curcuminoids Inhibit the Angiogenic Response Stimulated by Fibroblast Growth Factor-2, Including Expression of Matrix Metalloproteinase Gelatinase B*
R. Mohan (2000)
10.1016/J.CARBPOL.2011.01.005
Preparation, characterization, in vitro drug release and biological studies of curcumin loaded dextran sulphate–chitosan nanoparticles
A. Anitha (2011)
10.3109/03639040903061355
Microencapsulation of isoniazid in genipin-crosslinked gelatin-A–κ-carrageenan polyelectrolyte complex
N. Devi (2010)
10.1021/cr068445e
Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications.
S. Laurent (2008)
Anticancer potential of curcumin: preclinical and clinical studies.
B. Aggarwal (2003)
10.1111/j.2042-7158.1994.tb03854.x
Calcitonin and Insulin in Isobutylcyanoacrylate Nanocapsules: Protection Against Proteases and Effect on Intestinal Absorption in Rats
P. J. Lowe (1994)
10.2174/092986710790149738
Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications.
G. Bar-Sela (2010)
10.1006/CLIM.1999.4769
Curcumin causes the growth arrest and apoptosis of B cell lymphoma by downregulation of egr-1, c-myc, bcl-XL, NF-kappa B, and p53.
S. Han (1999)
10.1021/JM700988F
Design and development of water-soluble curcumin conjugates as potential anticancer agents.
A. Safavy (2007)
10.1038/sj.bjc.6601623
Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration
G. Garcea (2004)
10.1165/AJRCMB.20.4.3366
Prognostic role of cyclin D1 in lung cancer. Relationship to proliferating cell nuclear antigen.
M. Caputi (1999)
10.2147/IJN.S1608
Magnetic nanoparticles for gene and drug delivery
S. McBain (2008)
10.1159/000233309
Antibodies against polyethylene glycol produced in animals by immunization with monomethoxy polyethylene glycol modified proteins.
A. W. Richter (1983)
10.1016/S0968-0896(00)82152-5
Inhibition of the HIV-1 and HIV-2 proteases by curcumin and curcumin boron complexes.
Z. Sui (1993)
Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis.
S. Perkins (2002)
10.1186/1477-3155-5-1
Quantum dot-induced cell death involves Fas upregulation and lipid peroxidation in human neuroblastoma cells
A. Choi (2007)
10.1021/MP034006H
Molecular properties of WHO essential drugs and provisional biopharmaceutical classification.
N. A. Kasim (2004)
10.1177/1934578X1000500621
Colon Targeted Curcumin Delivery Using Guar Gum
Edwin J. Elias (2010)
10.1006/BBRC.1997.6527
Curcumin and genistein, plant natural products, show synergistic inhibitory effects on the growth of human breast cancer MCF-7 cells induced by estrogenic pesticides.
S. Verma (1997)
10.1016/j.ijbiomac.2013.03.029
Characterization of N-trimethyl chitosan/alginate complexes and curcumin release.
A. Martins (2013)
10.1007/s10989-004-2433-4
Chitosan-dextran Sulfate Nanoparticles for Delivery of an Anti-angiogenesis Peptide
Y. Chen (2004)
10.1002/CBER.191304602149
Studien über Curcumin
V. Lampe (1913)
10.1016/J.BIOMATERIALS.2004.07.050
Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs.
K. Y. Win (2005)
10.1021/JM020200G
Antitumor agents. 217. Curcumin analogues as novel androgen receptor antagonists with potential as anti-prostate cancer agents.
H. Ohtsu (2002)
10.1016/j.carbpol.2012.04.036
Preparation and characterization of cationic curcumin nanoparticles for improvement of cellular uptake.
J. Liu (2012)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar